Benelux site
A collaborative and experienced partner
We partner with innovative pharma, digital health ‘pioneers’, tech platforms, distributors and suppliers who share our goal to sustainably improve the patient experience and communities they are part of.
The life cycle
management company
Learn more
Committed to realising the full potential of established medicines
We use patient and clinician insights to identify areas of ongoing unmet need, then use our expertise as a leader in life cycle management to find innovative ways to deliver better outcomes for patients.
More about usOur numbers
-
10+
Offices
-
20+
Brands
-
160+
Markets
-
280+
Employees
Our portfolio
Cardiovascular
Our key products include Inderal®, Tenormin®, Tenoretic®, Zestril®and Zestoretic®
Endocrinology
Our key products include Bonviva®, Rocaltrol® and Synacthen®
Neurology
Our key products include Anaprox®, Naprosyn®, Toradol® and Valium®
Oncology
Our key products include Bondronat®, Dipentum® and Kytril®
A team of inquisitive minds
Pharmanovia’s success is down to its people. Our inclusive, high-performance culture provides opportunities to continually learn, develop and make change happen.
Latest news
17th May 2023
Closed Loop Medicine and Pharmanovia enter a global co-development partnership for precision medicine combination therapeutics
London and Basildon, UK, 17 May 2023: Closed Loop Medicine Ltd, a leading TechBio company, developing...
More information
3rd April 2023
Pharmanovia received SBTi approval for Net Zero Emissions Targets
Basildon, UK, 3rd April 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the...
More information
29th March 2023
Pharmanovia expands exclusive licensing collaboration with Aquestive Therapeutics
For Trade, Business and Medical Media only Basildon, UK – For immediate release, 27 March 2023...
More informationOur memberships
We are proud to be a member of EMIG, the Ethical Medicines Industry Group, and Medicines for Europe.
